(Q84514820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

hepatocellular carcinoma

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Olivier Séror

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Gisèle N'Kontchou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Amel Mahamoudi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mounir Aout

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Véronique Grando

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Emmanuelle Coderc

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Eric Vicaut

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jean Claude Trinchet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nicolas Sellier

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Michel Beaugrand

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1475-1483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

6 February 2020

cites work

1 reference

7 January 2021

Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series

1 reference

7 January 2021

Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.

1 reference

7 January 2021

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

7 January 2021

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

7 January 2021

Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis

1 reference

7 January 2021

Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients

1 reference

7 January 2021

Treatment and prognosis of hepatocellular carcinoma: a population based study in France.

1 reference

7 January 2021

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

1 reference

7 January 2021

Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

7 January 2021

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma

1 reference

7 January 2021

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

1 reference

7 January 2021

The actual five-year survival rate of hepatocellular carcinoma patients after curative resection

1 reference

7 January 2021

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.

1 reference

7 January 2021

Radio Frequency Ablation for Hepatocellular Carcinoma in Cirrhotic Patients: Prognostic Factors for Survival

1 reference

7 January 2021

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

1 reference

7 January 2021

Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C

1 reference

7 January 2021

Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?

1 reference

7 January 2021

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma

1 reference

7 January 2021

Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients

1 reference

7 January 2021

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

1 reference

7 January 2021

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors

1 reference

7 January 2021

Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study

1 reference

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

7 January 2021

Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection

1 reference

7 January 2021

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

7 January 2021

Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation

1 reference

7 January 2021

Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma

1 reference

7 January 2021

Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.

1 reference

7 January 2021

Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy

1 reference

7 January 2021

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

1 reference

7 January 2021

Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome

1 reference

7 January 2021

Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis.

1 reference

7 January 2021

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

1 reference

7 January 2021

Sorafenib in advanced hepatocellular carcinoma

1 reference

7 January 2021

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

1 reference

7 January 2021

Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19731239%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference